Phathom

Quote




H pylori and acid supression? Are we in the mid 1990’s?

Prilosec and Prevacid are over the counter now.

Hilaroius that people would do this for a living. Does it even require a college degree?
 












anonymous said:
Hey, it's our office! It freekin matters dummy!
Click to expand...

More than that, it tells you exactly how the company really feels about you. Expense or Valued Employee!!

When they throw you in cheap shit cars, it says they could care less about you - so get ready to get screwed in other areas like salary offers, bonus pay which happens when it happens, layoffs, etc.
 




Phathom might be (hopefully not) another Redhill Pharma - stock near zero, they have Talicia for H Pylori with everything combined in 1 pill for improved compliance & ease of use, and a left for dead PAMORA (Movantik) road kill they picked up from AZ. Such a laugh!
 




Phathom Pharmaceuticals stock was trading at $19.67 at the beginning of 2022. Since then, PHAT stock has decreased by 62.2% and is now trading at $7.44....Actually now $7.18 - down 3.76% today, June 9th!!!

Hell, at one time it was trading at $54.60 on June 7, 2020, 2 years ago!! Redhill did the same thing.
 




From Yahoo Finance 1 month ago:
Big Risk Factors to consider with Phathom Pharma (PHAT)
1 Has less than 1 year of cash runway
2 Makes less than USD$1m in revenue ($0)
3 Currently unprofitable and not forecast to become profitable over the next 3 years
4 Volatile share price over the past 3 months

Also, I say this..... Some Director at Phathom named David Socks owns over 1.2 million shares and sold a but load all at once a few months back - here's the story!
OCTOBER 11, 2021 - David A Socks, Director at Phathom Pharmaceuticals (NASDAQ:PHAT), made a large insider sell on October 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Socks sold 18,000 shares of Phathom Pharmaceuticals at prices ranging from $32.05 to $32.66. The total transaction amounted to $586,395.
Socks still owns a total of 1,211,756 shares of Phathom Pharmaceuticals worth, $38,976,131.
Phathom Pharmaceuticals shares are trading up 0.48% at $32.16 at the time of this writing on Monday afternoon

Today the stock closed at $7.17 x his 1,211,756 shares = $8,688,290.52
Looks like he has lost 30 MILLION DOLLARS in 8 months! Ouch!!

Used Ford Taureses for everbody!!!!!!
 




From Yahoo Finance 1 month ago:
Big Risk Factors to consider with Phathom Pharma (PHAT)
1 Has less than 1 year of cash runway
2 Makes less than USD$1m in revenue ($0)
3 Currently unprofitable and not forecast to become profitable over the next 3 years
4 Volatile share price over the past 3 months

Also, I say this..... Some Director at Phathom named David Socks owns over 1.2 million shares and sold a but load all at once a few months back - here's the story!
OCTOBER 11, 2021 - David A Socks, Director at Phathom Pharmaceuticals (NASDAQ:PHAT), made a large insider sell on October 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Socks sold 18,000 shares of Phathom Pharmaceuticals at prices ranging from $32.05 to $32.66. The total transaction amounted to $586,395.
Socks still owns a total of 1,211,756 shares of Phathom Pharmaceuticals worth, $38,976,131.
Phathom Pharmaceuticals shares are trading up 0.48% at $32.16 at the time of this writing on Monday afternoon

Today the stock closed at $7.17 x his 1,211,756 shares = $8,688,290.52
Looks like he has lost 30 MILLION DOLLARS in 8 months! Ouch!!

Used Ford Taureses for everbody!!!!!!
 




anonymous said:
From Yahoo Finance 1 month ago:
Big Risk Factors to consider with Phathom Pharma (PHAT)
1 Has less than 1 year of cash runway
2 Makes less than USD$1m in revenue ($0)
3 Currently unprofitable and not forecast to become profitable over the next 3 years
4 Volatile share price over the past 3 months

Also, I say this..... Some Director at Phathom named David Socks owns over 1.2 million shares and sold a but load all at once a few months back - here's the story!
OCTOBER 11, 2021 - David A Socks, Director at Phathom Pharmaceuticals (NASDAQ:PHAT), made a large insider sell on October 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Socks sold 18,000 shares of Phathom Pharmaceuticals at prices ranging from $32.05 to $32.66. The total transaction amounted to $586,395.
Socks still owns a total of 1,211,756 shares of Phathom Pharmaceuticals worth, $38,976,131.
Phathom Pharmaceuticals shares are trading up 0.48% at $32.16 at the time of this writing on Monday afternoon

Today the stock closed at $7.17 x his 1,211,756 shares = $8,688,290.52
Looks like he has lost 30 MILLION DOLLARS in 8 months! Ouch!!

Used Ford Taureses for everbody!!!!!!
Click to expand...

Sorry, but you needed Yahoo Finance to tell you that going to a single asset company to launch a new combination product for H. pylori is risky? I am sure it will be about as welcome to payers as PCSK-9's.
 




anonymous said:
Phathom might be (hopefully not) another Redhill Pharma - stock near zero, they have Talicia for H Pylori with everything combined in 1 pill for improved compliance & ease of use, and a left for dead PAMORA (Movantik) road kill they picked up from AZ. Such a laugh!
Click to expand...

Certainly not another redhill since Phathom's drug actually works. and if you listen to the IR calls you would know that h pylori launch is only a play for 5+ additional years of exclusivity. The money is in GERD and will be huge. I'm hoping most the dummies on this page don't make it through the final stages of the interview. Stay at Ironwood and your dead end AZ jobs and let me make $$$
 




anonymous said:
From Yahoo Finance 1 month ago:
Big Risk Factors to consider with Phathom Pharma (PHAT)
1 Has less than 1 year of cash runway
2 Makes less than USD$1m in revenue ($0)
3 Currently unprofitable and not forecast to become profitable over the next 3 years
4 Volatile share price over the past 3 months

Also, I say this..... Some Director at Phathom named David Socks owns over 1.2 million shares and sold a but load all at once a few months back - here's the story!
OCTOBER 11, 2021 - David A Socks, Director at Phathom Pharmaceuticals (NASDAQ:PHAT), made a large insider sell on October 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Socks sold 18,000 shares of Phathom Pharmaceuticals at prices ranging from $32.05 to $32.66. The total transaction amounted to $586,395.
Socks still owns a total of 1,211,756 shares of Phathom Pharmaceuticals worth, $38,976,131.
Phathom Pharmaceuticals shares are trading up 0.48% at $32.16 at the time of this writing on Monday afternoon

Today the stock closed at $7.17 x his 1,211,756 shares = $8,688,290.52
Looks like he has lost 30 MILLION DOLLARS in 8 months! Ouch!!

Used Ford Taureses for everbody!!!!!!
Click to expand...

They announced a $300M royalty deal. Less than 1 year of cash runway... what a joke. You primary reps get dumber and dumber/
 




anonymous said:
Certainly not another redhill since Phathom's drug actually works. and if you listen to the IR calls you would know that h pylori launch is only a play for 5+ additional years of exclusivity. The money is in GERD and will be huge. I'm hoping most the dummies on this page don't make it through the final stages of the interview. Stay at Ironwood and your dead end AZ jobs and let me make $$$
Click to expand...

It's not a question of whether the drug works or not, it looks like it is better than existing options PPI's, H2's etc. Payers aren't going to be particularly keen on the reinvigoration of what you rightly point out is a HUGH and currently generic/OTC market. So the question really is, will the doc's be excited enough about the incremental efficacy to overcome the barriers Payers put up. My guess is no.
 




















anonymous said:
Anyone know anything about the timing of the Los Angeles reps? Im former Celgene and Phantom management seems like Celgene part 2. I want in.
Click to expand...

If there is a manager in place, then start date is Sept 12. If there is no manager in place, then a manager will be hired by sept 12, and territories hired by that manager for November-December start.
 












Top Bottom
Back
Quote